Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection12

KIR3DL1 is a highly polymorphic killer cell Ig-like receptor gene with at least 23 alleles described, including its activating counterpart, KIR3DS1. Recently, the KIR3DS1 allele has been shown to slow progression to AIDS in individuals expressing HLA-Bw4 with isoleucine at position 80. However, due to the lack of a specific Ab, KIR3DS1 expression and function is not well characterized. In this study, we demonstrate KIR3DS1 expression on a substantial subset of peripheral natural killer cells through its recognition by the mAb Z27. The fidelity of this detection method was confirmed by analysis of KIR3DS1 transfectants and the identification of a novel KIR3DS1 null allele. Interestingly, KIR3DS1 is also expressed by a small proportion of CD56+ T cells. We show that ligation of KIR3DS1 by Z27 leads to NK cell IFN-γ production and degranulation as assessed by expression of CD107a. Furthermore, we document the persistence of KIR3DS1+ NK cells in HIV-1 viremic patients. The high frequency of KIR3DS1 expression, along with its ability to activate NK cells, and its maintenance during HIV-1 viremia are consistent with the epidemiological data suggesting a critical role for this receptor in controlling HIV-1 pathogenesis.

[1]  M. Carrington,et al.  Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. , 2007, AIDS research and human retroviruses.

[2]  Des C. Jones,et al.  Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies , 2007, European journal of immunology.

[3]  G. Davies,et al.  Identification of bidirectional promoters in the human KIR genes , 2007, Genes and Immunity.

[4]  D. Nixon,et al.  Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1 , 2007, The Journal of Immunology.

[5]  P. Parham,et al.  Functional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells1 , 2007, The Journal of Immunology.

[6]  M. Carrington,et al.  Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 , 2007, The Journal of Immunology.

[7]  P. Parham Taking license with natural killer cell maturation and repertoire development , 2006, Immunological reviews.

[8]  S. Anderson,et al.  Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! , 2006, Immunological reviews.

[9]  E. Thiel,et al.  The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells. , 2006, Experimental hematology.

[10]  E. Kistner,et al.  Reprogramming of CTLs into natural killer–like cells in celiac disease , 2006, The Journal of experimental medicine.

[11]  J. Lubkowski,et al.  The Structure of the Extracellular Domain of Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 and Evidence for a Naturally Occurring Soluble Fragment* , 2006, Journal of Biological Chemistry.

[12]  P. Parham,et al.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.

[13]  M. Carrington,et al.  The impact of variation at the KIR gene cluster on human disease. , 2006, Current topics in microbiology and immunology.

[14]  A. Fauci,et al.  NK cells in HIV infection: paradigm for protection or targets for ambush , 2005, Nature Reviews Immunology.

[15]  Hendrik Streeck,et al.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. , 2005, Blood.

[16]  Eric Vivier,et al.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Poggi,et al.  Regulation of γδ T cell survival by soluble HLA‐I: Involvement of CD8 and activating killer Ig‐like receptors , 2005 .

[18]  L. Rodrigo,et al.  Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. , 2005, Journal of Infectious Diseases.

[19]  R. Solana,et al.  CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype , 2005, Cancer Immunology, Immunotherapy.

[20]  Andrew Glass,et al.  Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci , 2005 .

[21]  J. Dillner,et al.  A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. , 2005, Tissue antigens.

[22]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[24]  Jessica M Malenfant,et al.  Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 , 2004, The Journal of Immunology.

[25]  P. Leibson,et al.  Stimulatory Killer Ig-Like Receptors Modulate T Cell Activation through DAP12-Dependent and DAP12-Independent Mechanisms1 , 2004, The Journal of Immunology.

[26]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[27]  S. Lockett,et al.  Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. , 2004, Immunity.

[28]  T. Chun,et al.  Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. , 2004, The Journal of infectious diseases.

[29]  R. Solana,et al.  Selective Depletion of CD56dim NK Cell Subsets and Maintenance of CD56bright NK Cells in Treatment-Naive HIV-1-Seropositive Individuals , 2002, Journal of Clinical Immunology.

[30]  P. Parham,et al.  The Protein Made from a Common Allele of KIR3DL1 (3DL1*004) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1 1 , 2003, The Journal of Immunology.

[31]  M. Daucher,et al.  Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Hsu,et al.  The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.

[33]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[34]  Ashok Kumar,et al.  Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10 , 2002, AIDS.

[35]  S. Topino,et al.  Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection. , 2001, Human immunology.

[36]  R. Morisset,et al.  Modulation of expression of the MHC class I‐binding natural killer cell receptors, and NK activity in relation to viral load in HIV‐infected/AIDS patients , 2001, Journal of medical virology.

[37]  Michael J. Wilson,et al.  The genomic context of natural killer receptor extended gene families , 2001, Immunological reviews.

[38]  D. Burshtyn,et al.  Intracellular Signaling by the Killer Immunoglobulin-Like Receptors and Ly49 , 2001, Science's STKE.

[39]  William H. Carr,et al.  Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.

[40]  M. Bonneville,et al.  Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.

[41]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[42]  J. Yen,et al.  Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.

[43]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Eric O Long,et al.  A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.

[45]  É. Vivier,et al.  Differential regulation of killer cell Ig‐like receptors and CD94 lectin‐like dimers on NK and T lymphocytes from HIV‐1‐infected individuals , 1999, European journal of immunology.

[46]  Eric O Long,et al.  Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.

[47]  J V Giorgi,et al.  Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[48]  A. Landay,et al.  Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. , 1995, Cytometry.

[49]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[50]  G. Ferrara,et al.  NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 , 1994, The Journal of experimental medicine.

[51]  Arthur Weiss,et al.  The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.

[52]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.